Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : GSLI Lumonics -- Ignore unavailable to you. Want to Upgrade?

To: pat mudge who wrote (53)	2/24/2000 7:03:00 PM
From: BMcV	Respond to of 328

Wow, Pat, nice to have you on the thread! Great job. I listened too, and heard four things that I was looking for: 1) lots of analysts on the call, some from major brokerages 2) divestiture of lower margin products (probably printers?) and concentration on three higher margin segments. 3) precision optics for telecom as one of those areas of investment, including probably some smaller acquisitions. Lots of questions, lots of comments about this. Clearly has analysts' imagination. 4) mention of biotech scanner. They think they have 60-70% of the market for scanners working on the genome project. What they left unsaid wisely is that this still represents a small business and will probably remain so. Medical/research instrumentation is just too small a market for much growth. Have some ideas on a new target I'll post later.

To: pat mudge who wrote (53)	2/24/2000 7:21:00 PM
From: James Calladine	Read Replies (1) \| Respond to of 328

PAT: Fantastic coverage of the CC! Thank you. Was thinking of waiting for the after-earnings sell off to buy in but things looked too strong today to wait. So bought 4.5 k shares today. Glad I did. Island shows last sale at $21! Again, many thanks. Best wishes, Jim

To: pat mudge who wrote (53)	2/24/2000 9:14:00 PM
From: john p. carney	Respond to of 328

Pat, excellent synopses. Thank you. eom

To: pat mudge who wrote (53)	2/25/2000 8:38:00 AM
From: BMcV	Read Replies (1) \| Respond to of 328

adjusted earnings: pretax net -- $6,354 add amortization -- $1,251 add foreign ex loss -- $1,767 subtract gain on sale -- $1,599 equals -- $7,773 subtract tax @ 33% -- $5,186 adj taxed EPS -- $0.15 Amortization should be taken out, since it reflects an accounting adjustment left over from the merger and will be taken every quarter for the next five years. Both the sale and the foreign exchange loss were one-time events, according to the CC, though I didn't catch the reason for such a large currency loss. The tax rate of 33% is the actual rate for this quarter.